Webhooks API
API webhooks is a salient feature of the Contify API services which helps the user to stay abreast with the updates related to their topics of interest.
Using this feature, notifications are sent to the user’s set URL as soon as the system identifies a new submission.
The user won’t be required to log-in into the API platform everytime to identify any updates as they will be regularly updated about any new events through the Webhooks notifications.
Configuring webhook
Webhook can be configured using the ADD Webhook button.
Mentioned below is the list of entities and operations supported for Webhooks.
If the user wishes to receive a notification covering their entire data and not specifically to some topics, then they can utilise the aq-include option and insert the ‘*:*’ command which will push notifications regarding every event to the user’s set URL.
| NAME |
Description |
Required |
Group |
| Name |
Any Relevant Name that you want |
true |
| URL |
URL that we send post request |
true |
| HEADER NAME |
Any name you want in HTTP_NAME key |
false |
| HEADER VALUE |
Any name you want in HTTP_SECRET key |
false |
| Tags ID |
The Tags ID you want the insights for |
|
Primary |
| KEYWORD |
Filter insights by keyword |
|
Primary |
| ADVANCED_QUERY |
Filter insights by an advance search query that must include a set of keywords. (To view available search operators, please login into your developer account and navigate to the description of "ADVANCED_QUERY" param under Insight API end point.) |
|
Primary |
Delivery headers
We support HEADER_PARAMETER If you add header name and header value fields you will
get these in your request.META dictionary as HTTP_NAME and HTTP_SECRET Keys.
Example delivery
{
"previous": null,
"story_count": 16,
"results": [
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8541,
"name": "Drug Delivery Devices"
}
],
"Product Type": [],
"source_name": "Mass Device",
"title": "Sanofi leads $50m round for Enable Injections’ on-body drug-delivery platform",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 3,
"name": "News Articles"
}
],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8864,
"name": "Enfuse"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/sanofi-35168.png",
"id": 26358,
"name": "Sanofi"
},
{
"logo": "//112233.contify.com/images/company/logo/enable-injections-159863.png",
"id": 384495,
"name": "Enable Injections"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "Enable Injections said last week that it closed a $50 million Series B round, led by Sanofi (NYSE:SNY), to fund the development of its enFuse on-body drug-delivery system.\n",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 3568,
"name": "Mass Device"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6546,
"name": "Partnership"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://www.massdevice.com/sanofi-leads-50m-round-for-enable-injections-on-body-drug-delivery-platform/<~csd>>https://www.massdevice.com/",
"pub_date": "2018-10-29T16:21:43Z",
"id": 119767944,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8802,
"name": "Orthopedic Robotic Systems"
}
],
"Product Type": [],
"source_name": "Mddionline",
"title": "Should Stryker Worry About Zimmer's New Robotics Offering?",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 22,
"name": "Reports & Studies"
}
],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7797,
"name": "Mako"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8803,
"name": "Rosa"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/stryker-corp-41216.png",
"id": 143894,
"name": "Stryker Corporation"
},
{
"logo": "//112233.contify.com/images/company/logo/zimmer-holdings-inc-fullcontact-20161103-43690.png",
"id": 214743,
"name": "Zimmer Biomet"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7363,
"name": "Orthopedics"
}
],
"summary": "Stryker's Mako Total Knee offering continues to gain traction and drive growth for the Kalamazoo, MI-based orthopedics company, but the company faces imminent competition in the space from Warsaw, IN-based Zimmer Biomet. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 85517,
"name": "Mddionline"
}
],
"Events Type": [],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://www.mddionline.com/should-stryker-worry-about-zimmers-new-robotics-offering<~csd>>https://mddionline.com/",
"pub_date": "2018-10-26T21:23:31Z",
"id": 120011207,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 68,
"name": "Australia"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 285,
"name": "Poland"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8502,
"name": "Pain Management Devices"
}
],
"Product Type": [],
"source_name": "Mass Device",
"title": "Medtronic wins FDA nod for SynchroMedII myPTM drug therapy manager",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 3,
"name": "News Articles"
}
],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7695,
"name": "SynchroMedII myPTM"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/download (3)-42423.png",
"id": 14658,
"name": "Medtronic"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "Medtronic (NYSE:MDT) said today that the FDA approved its new SynchroMedII myPTM personal therapy manager intended for use in treating patients with chronic pain.\n",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 3568,
"name": "Mass Device"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6538,
"name": "Product Launch"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://www.massdevice.com/medtronic-wins-fda-nod-for-synchromedii-myptm-drug-therapy-manager/<~csd>>https://www.massdevice.com/",
"pub_date": "2018-10-24T15:32:29Z",
"id": 119143245,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 73,
"name": "Canada"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 425,
"name": "Israel"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8540,
"name": "Respiratory and Sleep Management Devices"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7925,
"name": "Continuous positive airway pressure treatment"
}
],
"source_name": "Mass Device",
"title": "ResMed touts German win in continued Fisher & Paykel patent spat",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 3,
"name": "News Articles"
}
],
"Brand": [],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/resmed-india-pvt-ltd-3562.png",
"id": 107203,
"name": "ResMed Inc."
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 389365,
"name": "Fisher & Paykel Healthcare"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6522,
"name": "Aesthetics"
}
],
"summary": "ResMed (NYSE:RMD) yesterday touted a win in a German patent spat over masks used with continuous positive airway pressure machines with competitor Fisher & Paykel Healthcare (NZE:FPH). ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 3568,
"name": "Mass Device"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6647,
"name": "Legal issues"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://www.massdevice.com/resmed-touts-german-win-in-continued-fisher-paykel-patent-spat/<~csd>>https://www.massdevice.com/",
"pub_date": "2018-10-23T14:52:45Z",
"id": 118973004,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 207,
"name": "Germany"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8501,
"name": "Infusion Pumps"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8489,
"name": "Electronic Medical Records"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8859,
"name": "Acute Care Electronic Health Record"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8860,
"name": "General Purpose Infusion Pump"
}
],
"source_name": "Globe Newswire",
"title": "B. Braun Space Infusion Pump Systems Compatible with Allscripts Sunrise",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 24,
"name": "Press Releases"
}
],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8861,
"name": "DoseGuard"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8857,
"name": "DoseTrac"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7889,
"name": "Sunrise"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/braun-58715.png",
"id": 188128,
"name": "B Braun Medical Inc"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8448,
"name": "Healthcare IT"
}
],
"summary": "BETHLEHEM, Pa., Oct. 18, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced today it has completed the bi-directional integration testing with Allscripts Sunrise™ electronic health record (EHR). The completion of this phase enables hospitals using Sunrise the ability to integrate B. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 17964,
"name": "Globe Newswire"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6536,
"name": "Clinical Results"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://globenewswire.com/news-release/2018/10/18/1623791/0/en/B-Braun-Space-Infusion-Pump-Systems-Compatible-with-Allscripts-Sunrise.html<~csd>>http://globenewswire.com/",
"pub_date": "2018-10-18T18:29:59Z",
"id": 122269375,
"previews": [],
"Locations": []
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8502,
"name": "Pain Management Devices"
}
],
"Product Type": [],
"source_name": "Mass Device",
"title": "Medtronic launches workflow system to help wean patients off oral opioids",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 3,
"name": "News Articles"
}
],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7698,
"name": "SynchroMed II"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/download (3)-42423.png",
"id": 14658,
"name": "Medtronic"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "Medtronic (NYSE:MDT) said today that it launched its Control Workflow system in the U.S. for use with its SynchroMed II intrathecal drug-delivery system.\nThe medtech titan is hoping that, combined with its pain pump, the workflow system can help physicians in weaning patients off oral opioids. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 3568,
"name": "Mass Device"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8789,
"name": "Publication of guidelines"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://www.massdevice.com/medtronic-launches-workflow-system-to-help-wean-patients-off-oral-opioids/<~csd>>https://www.massdevice.com/",
"pub_date": "2018-10-16T13:51:58Z",
"id": 118055847,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8501,
"name": "Infusion Pumps"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8502,
"name": "Pain Management Devices"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8805,
"name": "General Purpose Pump"
}
],
"source_name": "Globe Newswire",
"title": "B. Braun Premieres Its New Wireless Syringe Pump at NANN 2018",
"duplicates": [],
"Content Types": [],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7887,
"name": "Infusomat"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7896,
"name": "Perfusor"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/braun-58715.png",
"id": 188128,
"name": "B Braun Medical Inc"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "BETHLEHEM, Pa., Oct. 15, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc., a leader in infusion therapy and pain management, will premiere the wireless 2nd generation software for its Perfusor® Space Syringe Pump, at the 34th Annual National Association of Neonatal Nurses (NANN) conference from October 17-20, 2018 in Anaheim, California.\n",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 17964,
"name": "Globe Newswire"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7733,
"name": "Conference"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://globenewswire.com/news-release/2018/10/15/1621551/0/en/B-Braun-Premieres-Its-New-Wireless-Syringe-Pump-at-NANN-2018.html<~csd>>http://globenewswire.com/",
"pub_date": "2018-10-15T18:29:59Z",
"id": 122271031,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8502,
"name": "Pain Management Devices"
}
],
"Product Type": [],
"source_name": "PR Newswire",
"title": "Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation",
"duplicates": [],
"Content Types": [],
"Brand": [],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/alliqua-inc-41229.png",
"id": 183229,
"name": "Alliqua Inc"
},
{
"logo": "//112233.contify.com/company/thumbnail/166430.png",
"id": 166430,
"name": "Adynxx Inc"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": " Alliqua BioMedical, Inc. (Nasdaq: ALQA ) and Adynxx, Inc., a privately held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the majority owners of Alliqua's outstanding common stock on a fully-diluted basis. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 455963,
"name": "PR Newswire"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6547,
"name": "M&A"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://www.prnewswire.com/news-releases/alliqua-biomedical-inc-and-adynxx-inc-announce-merger-agreement-to-create-nasdaq-listed-clinical-stage-pharmaceutical-company-with-a-focus-on-pain-and-inflammation-300729959.html<~csd>>https://www.prnewswire.com/",
"pub_date": "2018-10-12T18:29:59Z",
"id": 122265021,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8501,
"name": "Infusion Pumps"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8489,
"name": "Electronic Medical Records"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8805,
"name": "General Purpose Pump"
}
],
"source_name": "Globe Newswire",
"title": "B. Braun Successfully Integrates with Cerner at McLaren Hospital",
"duplicates": [],
"Content Types": [],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7887,
"name": "Infusomat"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8856,
"name": "Synchronized Intelligence"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8857,
"name": "DoseTrac"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8855,
"name": "AutoCOMPLETE"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8858,
"name": "Millenium"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7888,
"name": "Cerner’s Millennium®"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/braun-58715.png",
"id": 188128,
"name": "B Braun Medical Inc"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8448,
"name": "Healthcare IT"
}
],
"summary": "BETHLEHEM, Pa., Oct. 10, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced today the integration of their Infusomat® Space Large Volume Pumps with Cerner Millennium® electronic health record (EHR) platform at McLaren Greater Lansing Hospital, located in Lansing, Michigan.\n",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 17964,
"name": "Globe Newswire"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7800,
"name": "Product Approval"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://globenewswire.com/news-release/2018/10/10/1619632/0/en/B-Braun-Successfully-Integrates-with-Cerner-at-McLaren-Hospital.html<~csd>>http://globenewswire.com/",
"pub_date": "2018-10-10T18:29:59Z",
"id": 122269370,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8501,
"name": "Infusion Pumps"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8489,
"name": "Electronic Medical Records"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8805,
"name": "General Purpose Pump"
}
],
"source_name": "Icumed",
"title": "Plum 360™ Smart Pump Integration With Allscripts Sunrise™ EHR",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 24,
"name": "Press Releases"
}
],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7864,
"name": "Plum 360™"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7889,
"name": "Sunrise"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/AllScripts-41167.png",
"id": 185627,
"name": "Allscripts Healthcare Solutions Inc"
},
{
"logo": "//112233.contify.com/images/company/logo/icu-medical-inc-96280.png",
"id": 148423,
"name": "ICU Medical Inc"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8448,
"name": "Healthcare IT"
}
],
"summary": "Plum 360™ Pump Integration With Allscripts Sunrise™ EHR The integration of ICU Medical MedNet™ with this global health IT leader provides clinicians with reduced workflow steps, accurate infusion setup and timely documentation. SAN CLEMENTE, Calif., Sept. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 122477,
"name": "Icumed"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6546,
"name": "Partnership"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "http://www.icumed.com/about-us/news-events/news-articles/plum-360™-smart-pump-integration-with-allscripts-sunrise™-ehr.aspx<~csd>>http://icumed.com/",
"pub_date": "2018-10-09T18:29:59Z",
"id": 121889472,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8525,
"name": "Surgical Navigation Systems"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8815,
"name": "Neurosurgery Navigation System"
}
],
"source_name": "stryker",
"title": "Stryker's Advanced Guidance Technologies announces partnerships with Synaptive Medical and Ziehm Imaging",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 24,
"name": "Press Releases"
}
],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8820,
"name": "RFD 3D"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8819,
"name": "BrightMatter Plan"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/synaptive-medical-175817.png",
"id": 196545,
"name": "Synaptive Medical"
},
{
"logo": "//112233.contify.com/images/company/logo/stryker-corp-41216.png",
"id": 143894,
"name": "Stryker Corporation"
},
{
"logo": "//112233.contify.com/images/company/logo/ziehm-imaging-gmbh-99927.png",
"id": 53646,
"name": "Ziehm Imaging GmbH"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "Expanded portfolio to be showcased at The Congress of Neurological Surgeons this week Stryker's Advanced Guidance Technologies business (formerly known as Stryker's Navigation business) announced today it has entered into strategic partnerships with Synaptive Medical and Ziehm Imaging, strengthening Stryker's position as a leader in surgical guidance. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 19286,
"name": "stryker"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6546,
"name": "Partnership"
}
],
"Procedure Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8818,
"name": "Tractography"
}
],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://www.stryker.com/us/en/about/news/2018/stryker-s-advanced-guidance-technologies-announces-partnerships-.html<~csd>>https://www.stryker.com/en-us",
"pub_date": "2018-10-08T18:29:59Z",
"id": 121605858,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8524,
"name": "Diabetes Care Devices"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8871,
"name": "Glucose Monitoring Device"
}
],
"source_name": "Seeking Alpha",
"title": "Abbott's next-gen FreeStyle Libre CGM CE Mark'd - Abbott Laboratories (NYSE:ABT)",
"duplicates": [],
"Content Types": [],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7862,
"name": "FreeStyle Libre 2"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/Abotta-30369.png",
"id": 104603,
"name": "Abbott Laboratories"
}
],
"Disease": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7854,
"name": "Diabetes"
}
],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "Abbott (ABT ) announces that its next-generation FreeStyle Libre 2 continuous glucose monitoring (CGM) system is now CE Mark certified. The device includes alarms to alert the user when blood sugar levels are out of range and an alarm if the sensor loses communication with the reader. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 47,
"name": "Seeking Alpha"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7800,
"name": "Product Approval"
}
],
"Procedure Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8872,
"name": "Continuous Glucose Monitoring"
}
],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://seekingalpha.com/news/3394129-abbotts-next-gen-freestyle-libre-cgm-ce-markd<~csd>>https://seekingalpha.com/",
"pub_date": "2018-10-01T18:29:59Z",
"id": 122262965,
"previews": [],
"Locations": []
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8501,
"name": "Infusion Pumps"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8502,
"name": "Pain Management Devices"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 9183,
"name": "Injections"
}
],
"source_name": "Globe Newswire",
"title": "B. Braun Launches Safety Engineered Port Access Needle",
"duplicates": [],
"Content Types": [],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7890,
"name": "Surecan"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/braun-58715.png",
"id": 188128,
"name": "B Braun Medical Inc"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "BETHLEHEM, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. has introduced its Surecan™ Safety II Port Access Needles, a safety engineered needle for accessing implanted intravenous ports. The safety mechanism offers a unique visual confirmation when successfully engaged. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 17964,
"name": "Globe Newswire"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6538,
"name": "Product Launch"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://globenewswire.com/news-release/2018/10/01/1587940/0/en/B-Braun-Launches-Safety-Engineered-Port-Access-Needle.html<~csd>>http://globenewswire.com/",
"pub_date": "2018-10-01T18:29:59Z",
"id": 122270871,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8511,
"name": "Neurostimulation Devices"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8558,
"name": "Vagus Nerve Stimulation Devices"
}
],
"source_name": "Livanova",
"title": "LivaNova VNS Therapy System for Drug-Resistant Epilepsy Could Save $77,000 Per Patient Over Five Years",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 24,
"name": "Press Releases"
}
],
"Brand": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7892,
"name": "Vagus Nerve"
}
],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/liva-105301.png",
"id": 205020,
"name": "LivaNova PLC"
}
],
"Disease": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7891,
"name": "Epilepsy"
}
],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that a new cost analysis found the Company’s Vagus Nerve Stimulation Therapy ® (VNS Therapy) System results in lower resource utilization and lower cost for drug-resistant epilepsy (DRE) patients when compared to continued treatment with anti-epileptic drugs (AEDs). ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 416573,
"name": "Livanova"
}
],
"Events Type": [],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://investor.livanova.com/news-releases/news-release-details/livanova-vns-therapy-system-drug-resistant-epilepsy-could-save<~csd>>http://livanova.com/",
"pub_date": "2018-09-04T18:29:59Z",
"id": 121956853,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [],
"Product Type": [],
"source_name": "3M",
"title": "3M Files Additional Lawsuit to Enforce Its Patent Rights in Metal Mesh Conductor Technology Used in Touch Screens",
"duplicates": [],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 24,
"name": "Press Releases"
}
],
"Brand": [],
"Companies": [
{
"logo": "//112233.contify.com/images/company/logo/3m-33489.png",
"id": 92689,
"name": "3M Co"
}
],
"Disease": [],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "ST. PAUL, Minn.--(BUSINESS WIRE)--3M and 3M Innovative Properties Co. filed a patent infringement lawsuit today in federal district court in Las Vegas, Nev., against South Korea-based Tovis Co. Ltd. and its subsidiary Tovis North America, and Scientific Games Corporation. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 74309,
"name": "3M"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6647,
"name": "Legal issues"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7725,
"name": "Patent Dispute"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 0,
"source_url": "https://news.3m.com/press-release/company-english/3m-files-additional-lawsuit-enforce-its-patent-rights-metal-mesh-condu<~csd>>https://3m.com/",
"pub_date": "2018-08-20T18:29:59Z",
"id": 120785382,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
}
]
},
{
"Device Series": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8511,
"name": "Neurostimulation Devices"
}
],
"Product Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8875,
"name": "Deep Brain Stimulation Devices"
}
],
"source_name": "Contify",
"title": "Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy : Medical Alley Association",
"duplicates": [
{
"summary": "Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for Medtronic’s Deep Brain Stimulation (DBS) therapy as adjunctive treatment for reducing the frequency of partial-onset seizures, in individuals 18 years of age or older who are refractory, or drug-resistant, to three or more antiepileptic medications. DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus (ANT), which is part of a network involved in seizures.",
"source_name": "Medicalalley",
"id": 124787867,
"source_url": "https://medicalalley.org/2018/05/medtronic-receives-fda-approval-for-deep-brain-stimulation-therapy-for-medically-refractory-epilepsy/<~csd>>https://medicalalley.org/",
"title": "Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy : Medical Alley Association"
}
],
"Content Types": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 24,
"name": "Press Releases"
}
],
"Brand": [],
"Companies": [
{
"logo": "//112233.contify.com/client_data/company/logo/medical-alley-614442",
"id": 614442,
"name": "Medical Alley"
},
{
"logo": "//112233.contify.com/images/company/logo/download (3)-42423.png",
"id": 14658,
"name": "Medtronic"
}
],
"Disease": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7891,
"name": "Epilepsy"
}
],
"Therapy Area": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 8447,
"name": "Other Medical Technology"
}
],
"summary": "7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy. DUBLIN – May 1, 2018 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. ",
"Sources": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 1130,
"name": "Contify"
}
],
"Events Type": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 7800,
"name": "Product Approval"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 6536,
"name": "Clinical Results"
}
],
"Procedure Type": [],
"image_url": "",
"duplicate_count": 1,
"source_url": "https://www.contify.com/url/n5fOpmOxfrtpiQV2eSF_DaKzcMw==<~csd>>https://www.contify.com/",
"pub_date": "2018-05-01T18:29:59Z",
"id": 124802869,
"previews": [],
"Locations": [
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 97,
"name": "United States of America"
},
{
"logo": "//112233.contify.com/images/tags-ico.png",
"id": 230,
"name": "Ireland"
}
]
}
],
"next": null
}